Radioiodinated estrogen derivatives. 1980

J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba

Monoiodohexestrol exhibits 10 to 15% specific binding to the 8S estrogen receptor while the remainder binds to nonreceptor 4S proteins. Reduction of nonreceptor binding with either thyroxine or 8-anilino-1-naphthalene sulfonic acid was not quantitative. Thus no accurate determination of the concentration of receptor sites in the radioreceptor assay was possible by graphical analysis. Two additional estrogens--17 alpha [125I]iodoethynylestradiol and 17 alpha-[125I]iodoethynyl-11 beta-methoxy estradiol--were synthesized at high specific activity. Although the iodoethynyl derivatives were stable under synthetic conditions, deiodination in the presence of proteins is too fast to allow either in vivo or in vitro use. To make these compounds clinically useful, therefore, chemical modification to reduce nonreceptor binding and the rate of dehalogenation must be undertaken.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D006589 Hexestrol A synthetic estrogen that has been used as a hormonal antineoplastic agent. Dihydrodiethylstilbestrol,Hexestrol, (R*,R*)-(+-)-Isomer,Hexestrol, (R*,S*)-Isomer,Hexestrol, (R-(R*,R*))-Isomer,Hexestrol, (S-(R*,R*))-Isomer
D000817 Anilino Naphthalenesulfonates A class of organic compounds which contain an anilino (phenylamino) group linked to a salt or ester of naphthalenesulfonic acid. They are frequently used as fluorescent dyes and sulfhydryl reagents. Naphthalenesulfonates, Anilino
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4
D045166 Estradiol Congeners Steroidal compounds related to ESTRADIOL, the major mammalian female sex hormone. Estradiol congeners include important estradiol precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with estrogenic activities. Estradiol Congener,Estrogen Analog,Estrogen Analogue,Synthetic Estrogen,Estrogen Analogs,Estrogen Analogues,Estrogens, Synthetic,Synthetic Estrogens,Analog, Estrogen,Analogs, Estrogen,Analogue, Estrogen,Analogues, Estrogen,Congener, Estradiol,Estrogen, Synthetic

Related Publications

J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
February 2022, ACS medicinal chemistry letters,
J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
August 1967, Journal of pharmaceutical sciences,
J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
March 1969, Journal of medicinal chemistry,
J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
September 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
October 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
December 2020, Chemical biology & drug design,
J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
July 1984, Journal of chromatography,
J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
September 1968, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
January 2011, Nuclear medicine and biology,
J K Mazaitis, and R E Gibson, and T Komai, and W C Eckelman, and B Francis, and R C Reba
August 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!